Lipetz Jason, Zelinger Perry, Kline Myriam, Chahine Nadeen, Bloom Ona
Physical Medicine and Rehabilitation, Hofstra-Northwell School of Medicine/ Long Island Spine Rehabilitation Medicine, Great Neck, USA.
Physical Medicine and Rehabilitation, Rusk Rehabilitation, NYU Langone Health, New York, USA.
Cureus. 2020 Feb 26;12(2):e7104. doi: 10.7759/cureus.7104.
Introduction Recent studies on the use of transforaminal epidural steroid injection (TFESI) to treat lumbar radicular pain have highlighted controversies pertaining to the choice of corticosteroid agent utilized in lumbosacral TFESI, in terms of both safety and efficacy. The primary objective was to characterize the radicular pain response after a first transforaminal injection with dexamethasone. The secondary objective was to document the response of those who failed to respond to a dexamethasone injection when particulate steroid was utilized for a second injection. Methods It was a retrospective study of 94 consecutive patients undergoing transforaminal injection for lumbosacral radicular pain. At two-week follow-up, patients rated their pain response on a clinically oriented five-point survey. First injection non-responders were given a second injection with particulate steroid and again completed the survey. Results Approximately one-third (N = 31/94) of patients received no meaningful relief from a single injection with dexamethasone. No patients achieved lasting and complete pain relief after a single injection. Of initial non-particulate steroid non-responders, approximately two-thirds (N = 19/28) demonstrated a notable or complete response to a second injection with particulate steroid. Conclusions We are now able to better inform patients with regard to their anticipated pain response to an initial dexamethasone injection. Only one-third of patients realized more significant and lasting relief after a single injection. Of those who did not demonstrate a more meaningful response, a second injection with particulate steroid resulted in more pronounced pain relief in two-thirds of patients.
引言 近期关于使用经椎间孔硬膜外类固醇注射(TFESI)治疗腰椎神经根性疼痛的研究凸显了在腰骶部TFESI中使用的皮质类固醇药物选择在安全性和有效性方面存在的争议。主要目的是描述首次经椎间孔注射地塞米松后的神经根性疼痛反应。次要目的是记录那些首次注射地塞米松无效而第二次注射使用颗粒状类固醇时的反应。方法 这是一项对94例连续接受经椎间孔注射治疗腰骶部神经根性疼痛患者的回顾性研究。在两周随访时,患者根据以临床为导向的五点调查对疼痛反应进行评分。首次注射无反应者接受第二次颗粒状类固醇注射,并再次完成调查。结果 约三分之一(N = 31/94)的患者单次注射地塞米松后未获得明显缓解。单次注射后无患者实现持久且完全的疼痛缓解。在首次非颗粒状类固醇无反应者中,约三分之二(N = 19/28)在第二次注射颗粒状类固醇后表现出明显或完全反应。结论 我们现在能够更好地告知患者其对首次地塞米松注射的预期疼痛反应。只有三分之一的患者单次注射后实现了更显著和持久的缓解。在那些未表现出更有意义反应的患者中,三分之二的患者第二次注射颗粒状类固醇后疼痛缓解更明显。